Evidence map›Paper›PMID 27597964›Full record

ReviewBioMed research international2016

Differential Regulatory Analysis Based on Coexpression Network in Cancer Research.

Junyi Li, Yi-Xue Li, Yuan-Yuan Li

Abstract readReview
In one paragraph

Review in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Junyi LiKey Lab of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China; Shanghai Center for Bioinformation Technology, 1278 Keyuan Road, Shanghai 201203, China.ORCID 0000-0001-8045-5264
Yi-Xue LiKey Lab of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China; Shanghai Center for Bioinformation Technology, 1278 Keyuan Road, Shanghai 201203, China; Shanghai Industrial Technology Institute, 1278 Keyuan Road, Shanghai 201203, China; Shanghai Engineering Research Center of Pharmaceutical Translation, 1278 Keyuan Road, Shanghai 201203, China.ORCID 0000-0002-1198-7176
Yuan-Yuan LiShanghai Center for Bioinformation Technology, 1278 Keyuan Road, Shanghai 201203, China; Shanghai Industrial Technology Institute, 1278 Keyuan Road, Shanghai 201203, China; Shanghai Engineering Research Center of Pharmaceutical Translation, 1278 Keyuan Road, Shanghai 201203, China.ORCID 0000-0001-8755-4695

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With rapid development of high-throughput techniques and accumulation of big transcriptomic data, plenty of computational methods and algorithms such as differential analysis and network analysis have been proposed to explore genome-wide gene expression characteristics. These efforts are aiming to transform underlying genomic information into valuable knowledges in biological and medical research fields. Recently, tremendous integrative research methods are dedicated to interpret the development and progress of neoplastic diseases, whereas differential regulatory analysis (DRA) based on gene coexpression network (GCN) increasingly plays a robust complement to regular differential expression analysis in revealing regulatory functions of cancer related genes such as evading growth suppressors and resisting cell death. Differential regulatory analysis based on GCN is prospective and shows its essential role in discovering the system properties of carcinogenesis features. Here we briefly review the paradigm of differential regulatory analysis based on GCN. We also focus on the applications of differential regulatory analysis based on GCN in cancer research and point out that DRA is necessary and extraordinary to reveal underlying molecular mechanism in large-scale carcinogenesis studies.

Indexed as

CarcinogenesisGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksGenome, HumanHumansNeoplasm ProteinsNeoplasmsTranscriptomeNeoplasm Proteins

Identifiers

PMID27597964
PMCPMC4997028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.